Back
Editas Medicine Vs. Biogen Industry Stock Comparison
Sell
40
EDIT
Editas Medicine
Last Price:
3.92
Seasonality Move:
2.24%
Sell
30
BIIB
Biogen
Last Price:
201.42
Seasonality Move:
9.16%
Sell
40
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
- The current Editas Medicine [EDIT] share price is $3.93. The Score for EDIT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- EDIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Biogen (BIIB)
is a Sell
Is Biogen a Buy, Sell or Hold?
- The current Biogen [BIIB] share price is $201.44. The Score for BIIB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- BIIB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $3.93
The current trend is relatively stagnant and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.
BIIB Stock Price Chart
EDIT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 49.62 | Sell |
| Chaikin Money Flow: | -1368964 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.62 - 3.98) | Buy |
| Bollinger Bands (100): | (4.1 - 5.62) | Sell |
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.57 | Sell |
| Relative Strength Index (14 RSI): | 47.38 | Sell |
| Chaikin Money Flow: | -356051 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (199.12 - 205.1) | Sell |
| Bollinger Bands (100): | (204.91 - 229.03) | Sell |
EDIT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.84 | Buy |
| 20-day SMA: | 3.74 | Buy |
| 50-day SMA: | 4.41 | Sell |
| 200-day SMA: | 6.58 | Sell |
| 8-day EMA: | 3.83 | Buy |
| 20-day EMA: | 3.86 | Buy |
| 50-day EMA: | 4.26 | Sell |
| 200-day EMA: | 6.04 | Sell |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 198.71 | Buy |
| 20-day SMA: | 201.58 | Sell |
| 50-day SMA: | 208.53 | Sell |
| 200-day SMA: | 223.7 | Sell |
| 8-day EMA: | 199.41 | Buy |
| 20-day EMA: | 201.31 | Buy |
| 50-day EMA: | 207.06 | Sell |
| 200-day EMA: | 223.27 | Sell |
Editas Medicine Earnings Growth & EDIT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.66 per share, and an increase next year of $0.19 per share.
Biogen Earnings Growth & BIIB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.03 per share, an increase this year of $1.16 per share, and an increase next year of $0.78 per share.
Editas Medicine Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biogen Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||